BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12932288)

  • 1. Higher susceptibility to Fas ligand induced apoptosis and altered modulation of cell death by tumor necrosis factor-alpha in periarticular tenocytes from patients with knee joint osteoarthritis.
    Machner A; Baier A; Wille A; Drynda S; Pap G; Drynda A; Mawrin C; Bühling F; Gay S; Neumann W; Pap T
    Arthritis Res Ther; 2003; 5(5):R253-61. PubMed ID: 12932288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered expression of membrane-bound and soluble CD95/Fas contributes to the resistance of fibrotic lung fibroblasts to FasL induced apoptosis.
    Bühling F; Wille A; Röcken C; Wiesner O; Baier A; Meinecke I; Welte T; Pap T
    Respir Res; 2005 Apr; 6(1):37. PubMed ID: 15833141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of soluble FAS, FAS ligand and tumour necrosis factor-alpha in patients with chronic HCV infection.
    Raghuraman S; Abraham P; Daniel HD; Ramakrishna BS; Sridharan G
    J Clin Virol; 2005 Sep; 34(1):63-70. PubMed ID: 16087126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of CD95 apoptotic signaling by interferon-gamma in human osteoarthritic chondrocytes is associated with increased expression of FLICE inhibitory protein.
    Grassi F; Piacentini A; Cristino S; Toneguzzi S; Facchini A; Lisignoli G
    Arthritis Rheum; 2004 Feb; 50(2):498-506. PubMed ID: 14872492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble Fas (FasB) regulates luteal cell apoptosis during luteolysis in murine ovaries.
    Komatsu K; Manabe N; Kiso M; Shimabe M; Miyamoto H
    Mol Reprod Dev; 2003 Aug; 65(4):345-52. PubMed ID: 12840807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decoy receptor 3 expressed in rheumatoid synovial fibroblasts protects the cells against Fas-induced apoptosis.
    Hayashi S; Miura Y; Nishiyama T; Mitani M; Tateishi K; Sakai Y; Hashiramoto A; Kurosaka M; Shiozawa S; Doita M
    Arthritis Rheum; 2007 Apr; 56(4):1067-75. PubMed ID: 17393415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of FLIP sensitizes rheumatoid synovial fibroblasts to Fas-mediated apoptosis.
    Palao G; Santiago B; Galindo M; Payá M; Ramirez JC; Pablos JL
    Arthritis Rheum; 2004 Sep; 50(9):2803-10. PubMed ID: 15457448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble Fas ligand in the joints of patients with rheumatoid arthritis and osteoarthritis.
    Hashimoto H; Tanaka M; Suda T; Tomita T; Hayashida K; Takeuchi E; Kaneko M; Takano H; Nagata S; Ochi T
    Arthritis Rheum; 1998 Apr; 41(4):657-62. PubMed ID: 9550474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultraviolet B irradiation modulates susceptibility to tumour necrosis factor-alpha-induced apoptosis via induction of death receptors in murine fibroblasts.
    Kimura H; Minakami H; Shoji A
    Cell Biol Int; 2001; 25(12):1221-8. PubMed ID: 11748915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis.
    Huerta-Yepez S; Vega M; Garban H; Bonavida B
    Clin Immunol; 2006 Sep; 120(3):297-309. PubMed ID: 16784892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour necrosis factor alpha (TNF-alpha) interferes with Fas-mediated apoptotic cell death on rheumatoid arthritis (RA) synovial cells: a possible mechanism of rheumatoid synovial hyperplasia and a clinical benefit of anti-TNF-alpha therapy for RA.
    Ohshima S; Mima T; Sasai M; Nishioka K; Shimizu M; Murata N; Yoshikawa H; Nakanishi K; Suemura M; McCloskey RV; Kishimoto T; Saeki Y
    Cytokine; 2000 Mar; 12(3):281-8. PubMed ID: 10704256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble Fas and soluble Fas ligand levels in patients with acute hepatic failure.
    Nakae H; Narita K; Endo S
    J Crit Care; 2001 Jun; 16(2):59-63. PubMed ID: 11481600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Parthenolide inhibits tumor necrosis factor-alpha induced catabolism of aggrecan in chondrocytes in osteoarthritis: in vitro experiment with cultured human chondrocytes].
    Zhou HQ; Zhang FC; Rk W
    Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(11):764-8. PubMed ID: 18683686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The involvement of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in atherosclerosis.
    Michowitz Y; Goldstein E; Roth A; Afek A; Abashidze A; Ben Gal Y; Keren G; George J
    J Am Coll Cardiol; 2005 Apr; 45(7):1018-24. PubMed ID: 15808757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor-alpha promotes macrophage-induced vascular smooth muscle cell apoptosis by direct and autocrine mechanisms.
    Boyle JJ; Weissberg PL; Bennett MR
    Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1553-8. PubMed ID: 12869351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fas-mediated induction of hepatocyte apoptosis in a neuroblastoma and hepatocyte coculture model.
    Chen MK; Strande LF; Beierle EA; Kain MS; Geldziler BD; Doolin EJ
    J Surg Res; 1999 Jun; 84(1):82-7. PubMed ID: 10334894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FADD deficiency sensitises Jurkat T cells to TNF-alpha-dependent necrosis during activation-induced cell death.
    Lawrence CP; Chow SC
    FEBS Lett; 2005 Nov; 579(28):6465-72. PubMed ID: 16289096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of tumor necrosis factor-alpha receptor 1 and tumor necrosis factor-related apoptosis-inducing ligand-(TRAIL) receptor-2/DR-5, but not Fas, in graft injury in live-donor liver transplantation.
    Tashiro H; Itamoto T; Ohdan H; Arihiro K; Tateaki Y; Nakahara H; Ochi M; Hino H; Mizunuma K; Hara H; Tokita D; Onoe T; Ishiyama K; Mitsuta H; Sugino K; Asahara T
    Transpl Int; 2004 Nov; 17(10):626-33. PubMed ID: 15502938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon (IFN)-gamma is a main mediator of keratinocyte (HaCaT) apoptosis and contributes to autocrine IFN-gamma and tumour necrosis factor-alpha production.
    Konur A; Schulz U; Eissner G; Andreesen R; Holler E
    Br J Dermatol; 2005 Jun; 152(6):1134-42. PubMed ID: 15948973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor-alpha promotes the expression of osteoprotegerin in rheumatoid synovial fibroblasts.
    Kubota A; Hasegawa K; Suguro T; Koshihara Y
    J Rheumatol; 2004 Mar; 31(3):426-35. PubMed ID: 14994384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.